DOD & HHS Announce DPA Title III Agreement with BioFire Defense, LLC to Expand Domestic Production Capacity for Molecular Diagnostic Testing
Posted on
As part of the national response to COVID-19, the Department of Defense, in coordination with the Department of Health & Human Services, signed an agreement with BioFire Defense, LLC, a subsidiary of bioMérieux, to expand the production of the BioFire® COVID-19 Test for the DOD.
Subscribe to our newsletter
Promotions, new products and sales. Directly to your inbox.
Quick links
© Copyright 2024, Morale Patch® Armory.